Role of RPA Hyperphosphorylation in DNA Damage Responses
Role of RPA Hyperphosphorylation in DNA Damage Responses
批准号:
8291307
负责人:
Moises Alejandro Serrano
金额:
$3.15万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2013-06-30
关键词:
AddressBindingBinding ProteinsBiochemicalBiologicalCell Cycle ProgressionCellsChemicalsCouplingDNADNA DamageDNA RepairDNA Repair PathwayDNA damage checkpointDNA lesionDataDiseaseDouble Strand Break RepairDown-RegulationEnvironmental HazardsEukaryotaExcisionExposure toFailureFellowshipGenetic RecombinationGoalsHealthHumanIndividualInstructionLaboratoriesMalignant NeoplasmsMediatingMetabolic PathwayMolecularMutagenesisMutagensMutationNational Research Service AwardsNerve DegenerationPathway interactionsPhosphotransferasesPlayPremature aging syndromeProteinsRegulationReplication InitiationReplication OriginRoleSS DNA BPSignal TransductionSingle-Stranded DNASourceSystemTestingTimeWorkbasehomologous recombinationhuman diseaseinsightorigin recognition complexpreventrepairedreplication factor Aresponsesuccessultraviolet irradiation
中文摘要
空间
提供了
环境危害,包括紫外线照射和遗传毒性化学品,是一些主要来源,
DNA损伤被认为是人类癌症的主要原因,也是许多其他癌症的原因。
如过早衰老和神经退化等疾病。DNA修复和DNA损伤检查点是
这两个主要的生物防御系统对抗细胞中的DNA损伤。这两者之间的协调
机械对于及时清除DNA损伤,防止DNA损伤转化为
由于复制不忠实而导致的永久性突变。然而,配位的分子细节仍然存在
大部分未知。作为真核生物中主要的单链DNA(ssDNA)结合蛋白,
蛋白A(protein A,RPA)参与几乎所有的DNA代谢途径,如复制、重组、DNA
损伤检查点和所有类型的DNA修复途径。尽管它在所有这些途径中具有重要的活性
RPA是否以及如何在DNA修复和修复之间的精确协调中发挥作用的问题,
检查点仍有待阐明。我们实验室最近的研究结果表明,RPA经历了
对DNA损伤的反应。在这个项目中,我们将测试的假设,
过度磷酸化可以改变RPA与ssDNA和蛋白质相互作用的生物化学活性,
因此可能构成了一种重要的调节机制,通过这种机制,一些DNA损伤反应相互作用
的分子相互作用的失败或成功,
RPA。为了验证这些假设,我们将具体确定:1)过度磷酸化RPA在
Rad 51/Rad 52与RPA之间的相互作用及RPA的影响
高磷酸化;和3)细胞分子相互作用刺激和/或破坏的
RPA过度磷酸化。本项目的长期目标是阐明
人类细胞中的DNA损伤反应,并更好地了解损伤诱导的诱变和
相关的人类疾病。
PHS 416-1(修订版9/08)第2页表格第2页底部连续编号
应用程序.不要使用后缀,如2a,2b。
Kirschstein-NRSA个人奖学金申请申请人姓名(姓、名、中间名首字母)
莫伊塞斯?塞拉诺
(To由申请人填写-遵循PHS 416-1指示)
18.
英文摘要
SPACE
PROVIDED.
Environmental hazards, including UV irradiation and genotoxic chemicals, are some of the major sources for
DNA damage and believed to be the major cause to human cancers and also a cause to many other
diseases such as premature aging and neurodegeneration. DNA repair and DNA damage checkpoints are
the two major biological defense systems against DNA damage in cells. Coordination between these two
machineries is crucial for timely removal of DNA damage, preventing the conversion of DNA lesions to
permanent mutations due to replication infidelity. However, the molecular details of the coordination remain
largely unknown. As the major single-stranded DNA (ssDNA) binding protein in eukaryotes, replication
protein A (RPA) is involved in almost all DNA metabolic pathways such as replication, recombination, DNA
damage checkpoints, and all types of DNA repair pathways. Despite its critical activity in all these pathways
the question of whether and how RPA plays a role in the precise coordination between DNA repair and
checkpoints remain to be elucidated. Recent findings from our laboratory have shown that RPA undergoes
hyperphosphorylatlon in response to DNA damage. In this project we will test the hypothesis that the
hyperphosphorylatlon may alter the biochemical activity of RPA for interaction with ssDNA and proteins, and
thus may constitute an important regulatory mechanism by which some DNA damage response interactions
are inhibited while others are activated owing to the failure or success of the molecular interactions with
RPA. To test these hypotheses, we will specifically determine: 1) the role of hyperphosphorylated RPA in
the suppression of origin firing; 2) the interaction between Rad51/Rad52 and RPA and its effect by RPA
hyperphosphorylatlon; and 3) the cellular molecular interactions stimulated and/or disrupted by the
hyperphosphorylation of RPA. The long-term goal of this project is to elucidate the molecular mechanism of
DNA damage responses in human cells, and to better understand the damage-induced mutagenesis and
related human diseases.
PHS 416-1 (Rev. 9/08) Page 2 Number pages consecutively at the bottom throughout Form Page 2
the application. Do not use suffixes such as 2a, 2b.
Kirschstein-NRSA Individual Fellowship Application NAME OF APPLICANT (Last, first, middle initial)
Serrano, Moises A
(To be completed by applicant - follow PHS 416-1 instructions)
18.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of RPA Hyperphosphorylation in DNA Damage Responses
-
批准号:7885488
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2009
-
负责人:Moises Alejandro Serrano
-
依托单位:
Role of RPA Hyperphosphorylation in DNA Damage Responses
-
批准号:8100340
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2009
-
负责人:Moises Alejandro Serrano
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: